Two Allegheny Health Network Physicians Receive Honor from Infectious Diseases Society of America
Wednesday, October 9, 2019
PITTSBURGH – Recognized as leaders in the field of infectious disease, Allegheny Health Network (AHN) physicians Nitin Bhanot, MD, MPH, and Zaw Min, MD, have been named Fellows of Infectious Diseases Society of America (IDSA). Dr. Bhanot and Dr. Min are joined in this honor by about 100 distinguished physicians and scientists from around the world.
According to the Society, Fellowship in ISDA honors those who have achieved professional excellence and provide significant service to the profession. Applicants are nominated by their peers and meet specified criteria that include continuing identification with the field of infectious diseases, national or regional recognition, and publication of their scholarly work.
In addition to his role as division director of infectious disease at AHN, Dr. Bhanot serves as program director for the infectious diseases fellowship at Allegheny General Hospital (AGH). Dr. Bhanot’s strong commitment to medical education and training in infectious disease has helped enhance the program’s national recognition.
Dr. Bhanot received his medical degree from Sri Devaraj Urs Medical College in Karnataka, India and has published more than 40 articles on the pathology and treatment of infectious disease in peer reviewed journals. In addition to the IDSA, he serves on national committees such as the American Board of Internal Medicine (ABIM) and the Accreditation Council for Graduate Medical Education (ACGME).
Dr. Min serves as the medical director of infection prevention at AGH, and research director of the division of infectious disease. He received his medical degree from the University of Medicine-1 in Yangon, Myanmar. He is also a member of the International Antiviral Society-USA, and Fellow of the American College Physicians. He has published more than 35 articles in several peer-reviewed journals, and notably led AGH’s participation in a multi-center phase III clinical trial of the efficacy and safety of Clostridioides difficile (C. diff) vaccine for people at risk of the infection.
“As physicians who play a critical role in protecting public health, our region is extremely fortunate to have the expertise of Dr. Bhanot and Dr. Min, two highly accomplished physicians who are committed to advancing the standards of care for patients who are afflicted by infectious disease,” said Susan Manzi, MD, MPH, Chair, AHN Medicine Institute. “We applaud them for this well-deserved national recognition.”